TY - JOUR T1 - Efficacy of a spatial repellent for control of malaria in Indonesia: a cluster-randomized controlled trial JF - medRxiv DO - 10.1101/19003426 SP - 19003426 AU - Din Syafruddin AU - Puji BS Asih AU - Ismail Ekoprayitno Rozi AU - Dendi Hadi Permana AU - Anggi Puspa Nur Hidayati AU - Lepa Syahrani AU - Siti Zubaidah AU - Dian Sidik AU - Michael J. Bangs AU - Claus Bøgh AU - Fang Liu AU - Evercita C. Eugenio AU - Jared Hendrickson AU - Timothy Burton AU - JK Baird AU - Frank Collins AU - John P. Grieco AU - Neil F. Lobo AU - Nicole L. Achee Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/08/31/19003426.abstract N2 - A randomized cluster, double-blinded, placebo-controlled trial was conducted to estimate protective efficacy of a spatial repellent against malaria infection at Sumba, Indonesia. Following radical cure in 1,332 children aged 6mo-5yrs in 24 clusters, households were given transfluthrin or placebo passive emanators. Monthly blood screening and biweekly human-landing mosquito catches (HLC) were performed during 10-months baseline (June 2015 to March 2016) and a 24-month intervention period (April 2016 to April 2018). Screening detected 164 first-time malaria infections and an accumulative total of 459 infections in 667 subjects in placebo-control households; and 134 first-time and 253 accumulative total infections among 665 subjects in active intervention households. The 24-cluster protective effect of 27.7% and 31.3%, for time to first-event and overall (total new) infections, respectively, was not statistically significant. Purportedly, this due in part to zero to low incidence in some clusters during intervention undermining the ability to detect an effect. Subgroup analysis of 19 clusters where at least one malaria infection occurred showed 36.0% and 40.9% (statistically significant at 1-sided 5% significance level; p=0.0236) protective effect for time to first-event and overall infections, respectively. Primary entomological analysis of impact proved not statistically significant, with indoor and outdoor anopheline HLC reduced by 16.4% and 11.3%, respectively. Among 12 high-risk clusters, a significant impact on infection was detected (about 60% protective efficacy). While this study suggests protective effects of the intervention, additional evidence is required to demonstrate that spatial repellents provide a practical and effective means in reducing malaria transmission.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02294188Funding StatementThis study was funded by a substantial award from the Bill & Melinda Gates Foundation (BMGF) to the University of Notre Dame (Grant# OPP1081737). We express our gratitude to the Foundation for their long-term generosity and support of spatial repellent product evaluation and development, especially Kate Aultman, Dan Strickman and Alan Magill. We are also deeply grateful to SC Johnson for its financial support. The company provided integral industry and product expertise including the development, manufacturing, delivery and shipment of the intervention (active and placebo) used in the study. Additionally, SC Johnson provided expertise in ensuring intervention quality, storage, application and disposal assurances throughout the trial.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.YesI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesAnalytical datasets available upon request to corresponding author. ER -